1 completed, 1 recruiting, 1 withdrawn. 2 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Pediatric Acute Leukemia: new trials by email Literature Review of Pediatric Acute Leukemia trials Research Report on Pediatric Acute Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and Relapsed /Refractory Pediatric Acute Leukemia Patients Revumenib, Cytrabine, Daunorubicin - Pediatric Acute Leukemia | Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2026-05-21 | 2026-09-23 | |
| Using Mobile Technology-assisted Outpatient Maintenance Therapy Pediatric ALL Health monitoring & reminders for a mobile-phone portal for scheduling a telemedicine clinic visit and receive periodic model-phone messages instructing follow-up blood testing and dose adjustment. - Pediatric Acute Leukemia | Not applicable | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 100 | 2025-12-01 | 2026-10-20 |
| Targeted High Throughput Sequencing in the Diagnosis of Pediatric Acute Leukemia blood draw - Pediatric Acute Leukemia | Not applicable | Completed | Assistance Publique Hopitaux De Marseille | 26 | 2014-02-04 | 2023-07-28 |
Blood Specimen Collection (1) · Daunorubicin (1) · revumenib (1)
Assistance Publique Hopitaux De Marseille (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · M.D. Anderson Cancer Center (1)
China (1) · France (1)